Allergan CEO Saunders could cash out Pfizer deal with $187M, Bloomberg figures

Eric Palmer

Even if Brent  does not get the CEO role at as a condition of agreeing to a buyout, which is reportedly being demanded, he will still get a huge payday from the . In the short time that he has been CEO of   he has collected shares and options that should allow him to out for nearly $ 190 million.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS